Literature DB >> 15741215

A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin.

Christina Trambas1, Federico Gallo, Daniela Pende, Stefania Marcenaro, Lorenzo Moretta, Carmela De Fusco, Alessandra Santoro, Luigi Notarangelo, Maurizio Arico, Gillian M Griffiths.   

Abstract

Mutations in the perforin gene have been found in patients with hemophagocytic lymphohistiocytosis (HLH), a rare autosomal recessive disease. We describe a patient expressing perforin with amino acid changes A91V and W374X. The ability of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells to lyse target cells is greatly reduced. Here we demonstrate that perforin from this patient is not recognized using an antibody raised against native perforin (deltaG9), but is readily detected using an antibody raised against a peptide epitope (2d4), suggesting that the epitope recognized by deltaG9 is destroyed by the change at A91V. Immunoblotting reveals no protein corresponding to the truncated transcript encoded by W374X, revealing that only perforin with the A91V change is expressed in CTLs from the patient. Patient CTLs show bands corresponding to the immature and intermediate forms of perforin, but the mature active form of perforin is absent or barely detectable. The conformational changes and impaired cleavage of A91V perforin are likely to explain the reduced cytotoxicity in CTLs and NK cells from this patient and are likely to contribute to the pathogenesis of HLH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741215     DOI: 10.1182/blood-2004-09-3713

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Molecular basis of familial hemophagocytic lymphohistiocytosis.

Authors:  Valentina Cetica; Daniela Pende; Gillian M Griffiths; Maurizio Aricò
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

2.  Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis.

Authors:  Kimberly A Risma; Robert W Frayer; Alexandra H Filipovich; Janos Sumegi
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

3.  Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  P A Mehta; S M Davies; A Kumar; M Devidas; S Lee; T Zamzow; J Elliott; J Villanueva; J Pullen; Y Zewge; A Filipovich
Journal:  Leukemia       Date:  2006-06-22       Impact factor: 11.528

Review 4.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

5.  Structural and functional analysis of perforin mutations in association with clinical data of familial hemophagocytic lymphohistiocytosis type 2 (FHL2) patients.

Authors:  Omer An; Attila Gursoy; Aytemiz Gurgey; Ozlem Keskin
Journal:  Protein Sci       Date:  2013-06       Impact factor: 6.725

6.  Analyses of the PRF1 gene in individuals with hemophagocytic lymphohystiocytosis reveal the common haplotype R54C/A91V in Colombian unrelated families associated with late onset disease.

Authors:  Isaura P Sánchez; Lucía C Leal-Esteban; Jesús A Álvarez-Álvarez; Camilo A Pérez-Romero; Julio C Orrego; Malyive L Serna; Yadira Coll; Yolanda Caicedo; Edwin Pardo-Díaz; Jacques Zimmer; Jack J Bleesing; José L Franco; Claudia M Trujillo-Vargas
Journal:  J Clin Immunol       Date:  2012-03-22       Impact factor: 8.317

7.  Perforin proteostasis is regulated through its C2 domain: supra-physiological cell death mediated by T431D-perforin.

Authors:  Amelia J Brennan; Ruby H P Law; Paul J Conroy; Tahereh Noori; Natalya Lukoyanova; Helen Saibil; Hideo Yagita; Annette Ciccone; Sandra Verschoor; James C Whisstock; Joseph A Trapani; Ilia Voskoboinik
Journal:  Cell Death Differ       Date:  2018-02-07       Impact factor: 15.828

8.  Prevalence and disease predisposition of p.A91V perforin in an aged population of European ancestry.

Authors:  Ilia Voskoboinik; Paul Lacaze; Helena Sung-In Jang; Thijs Flinsenberg; Suran L Fernando; Ian Kerridge; Moeen Riaz; Robert Sebra; Kevin Thia; Taherah Noori; Eric E Schadt; John J McNeil; Joseph A Trapani
Journal:  Blood       Date:  2020-02-20       Impact factor: 22.113

9.  Missense mutations in the perforin (PRF1) gene as a cause of hereditary cancer predisposition.

Authors:  Mohammed S Chaudhry; Kimberly C Gilmour; Imran G House; Mark Layton; Nicki Panoskaltsis; Mamta Sohal; Joseph A Trapani; Ilia Voskoboinik
Journal:  Oncoimmunology       Date:  2016-06-02       Impact factor: 8.110

Review 10.  Genetic defects in cytolysis in macrophage activation syndrome.

Authors:  Mingce Zhang; Edward M Behrens; T Prescott Atkinson; Bita Shakoory; Alexei A Grom; Randy Q Cron
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.